Paying prices we can ill afford

Paying prices we can ill afford

Medicines for Ireland claims policies on biosimilar products prevent taxpayers from gaining €25 million in savings on vital medicines

In a recent examination of hospital costs, the Department of Public Expenditure highlighted a €115 million increase in spending on medicines between 2014 and 2017.

Please Subscribe or Log in to continue reading

Subscribe Login

Independent journalism every day

With digital access you can read The Business Post whenever, wherever, and however you want.

  • Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
  • Breaking news, comment and analysis from the best Business Post writers seven days a week.
  • Live blogs of major news events
  • Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
  • Access to The Business Post's extensive archive​

Related Articles

More from The Business Post